Care.Kl

CARE.KL's capital structure is characterized by a relatively low debt-to-equity ratio of 0.15, indicating a conservative approach to financing. However, the company's liquidity position is rated as medium, with a current ratio of 1.58, suggesting it has sufficient short-term assets to cover its liabilities, but not with a large margin of safety. The company's free cash flow is negative at -85.7 million MYR, which is a concern for its ability to fund operations and growth without external financing.

Profitability metrics for CARE.KL are significantly below industry norms. The company reported a return on equity (ROE) of -37.75% and a return on assets (ROA) of -28.48%, both of which are negative and indicate poor performance relative to its asset base and equity. These figures are far below the typical positive returns expected in the healthcare equipment and supplies industry.

The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no significant geographic diversification reported. This lack of diversification increases the company's exposure to regional economic fluctuations and regulatory changes. The absence of detailed segment reporting limits the ability to assess the performance of different parts of the business.

CARE.KL's growth trajectory is uncertain, with the company reporting a net loss of 81.6 million MYR and a significant decline in operating income. The outlook for the current fiscal year is negative, with no clear signs of improvement in the near term. The company's capital expenditure of -18.1 million MYR suggests a reduction in investment in long-term assets, which could further hamper future growth.

The risk assessment for CARE.KL highlights several concerns. The company's liquidity risk is rated as medium, primarily due to its negative free cash flow and the need to manage short-term obligations. The dilution risk is currently low, but the company's negative net cash position after subtracting total debt raises concerns about potential future dilution if it needs to raise additional capital. The risk assessment also notes the company's negative operating cash flow, which could lead to increased financial stress.

Recent events and filings indicate that CARE.KL is facing significant financial challenges. The company's latest financial report shows a substantial decline in revenue and profitability, with a gross profit of -21.7 million MYR and an operating income of -76.2 million MYR. These figures suggest that the company is struggling to maintain its operations and may need to implement cost-cutting measures or seek external financing to stabilize its financial position.

Carter Bankshares achieves a net margin of 1.54%, significantly outperforming the 0.32% median for its banking cohort.

The company maintains a zero debt-to-equity ratio, indicating a conservative capital structure compared to the 0.28 cohort median.

Carter Bankshares trades at a 1.48x price-to-book multiple, reflecting a premium valuation relative to its tangible book value.

Revenue demonstrated a 6.0% compound annual growth rate over the two-year period from FY2023 to FY2025.

The firm exhibits low dilution risk, suggesting stable ownership structure and minimal threat to existing shareholder value.

Revenue contracted by 4.4% year-over-year in FY2025, indicating a reversal of previous growth momentum.

Total assets decreased by 4.0% year-over-year in FY2025, reflecting a shrinking balance sheet and potential business contraction.

Free cash flow dropped by 9.4% year-over-year in FY2025, highlighting weakening cash generation capabilities.